CDK5RAP3 and neoplasm: In our previous researches, we found that CDK5RAP3 can inhibit the phosphorylation of AKT in gastric cancer (6), thereby inhibiting the GSK-3β mediated phosphorylation, degrading β-catenin and acting as a tumour suppressor in the occurrence and progression of gastric cancer (7).